Monitoring-Based Model for Personalizing Fecal Incontinence in Patients With Crohn's Disease: A Multicenter Inception Cohort Study

被引:0
|
作者
Wang, Can [1 ]
Yang, Fan [2 ]
Qiao, Lichao [1 ]
Wang, Xiaoxiao [3 ]
Chen, Qi [1 ]
Chen, Hongjin [1 ]
Li, Yi [4 ]
Zhang, Xiaoqi [5 ]
Liao, Xiujun [6 ]
Cao, Lei [4 ,7 ]
Xu, Haixia [1 ]
Xiang, Yu [1 ]
Yang, Bolin [1 ]
机构
[1] Nanjing Univ Chinese Med, Jiangsu Prov Hosp Chinese Med, Affiliated Hosp, Dept Colorectal Surg, 155 Han Zhong Rd, Nanjing, Peoples R China
[2] Univ New South Wales, Sch Math & Stat, Dept Sci, Sydney, Australia
[3] Nanjing Univ Chinese Med, Affiliated Hosp, Jiangsu Prov Hosp Chinese Med, Dept GCP Res Ctr, Nanjing, Peoples R China
[4] Nanjing Univ, Jinling Hosp, Med Sch, Dept Gen Surg, Nanjing, Peoples R China
[5] Nanjing Univ Med Sch, Nanjing Drum Tower Hosp, Affiliated Hosp, Dept Gastroenterol, Nanjing, Peoples R China
[6] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Key Lab Canc Prevent,Minist Educ,Dept Colorectal S, Hangzhou, Peoples R China
[7] Nanjing Univ Tradit Chinese Med, Nanjing Hosp, Hosp Nanjing 2, Dept Gastroenterol, Nanjing, Peoples R China
关键词
Crohn's disease; fecal incontinence; risk factor; nomogram; INFLAMMATORY-BOWEL-DISEASE; PERIANAL FISTULAS; MANAGEMENT; CONSENSUS; OUTCOMES; SYMPTOM; URGENCY; BURDEN; OLDER;
D O I
10.1093/ibd/izae006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Fecal incontinence (FI) is a common complaint that greatly affects the quality of life of patients with Crohn's disease (CD) and is associated with the clinical characteristics of CD. We aimed to identify risk factors related to FI and construct a risk prediction model for FI in patients with CD. Methods: This retrospective study included 600 Chinese patients with CD from 4 IBD centers between June 2016 and October 2021. The patients were assigned to the training (n = 480) and testing cohorts (n = 120). Two nomograms were developed based on the logistic regression and Cox regression models to predict the risk factors for FI in patients with CD. The discriminatory ability and accuracy of the nomograms were evaluated using the receiver operating characteristic (ROC) curves and the area under the ROC curves (AUCs). Additionally, the Kaplan-Meier survival curve was also used further to validate the clinical efficacy of the Cox regression model. Results: The overall prevalence of FI was 22.3% (n = 134 of 600). In the logistic regression model, age at diagnosis (odds ratio [OR], 1.032; P = .033), penetrating behavior of disease (OR, 3.529; P = .008) and Perianal Disease Activity Index score >4 (OR, 3.068; P < .001) were independent risk factors for FI. In the Cox regression model, age at diagnosis (hazard ratio [HR], 1.027; P = .018), Montreal P classification (HR, 2.608; P = .011), and Perianal Disease Activity Index score >4 (HR, 2.190; P = .001) were independent predictors of the prevalence of FI over time. Two nomograms were developed to facilitate risk score calculation, and they showed good discrimination ability according to AUCs. Conclusions: In this study, we identified 4 risk factors related to the prevalence of FI and developed 2 models to effectively predict the risk scores of FI in CD patients, helping to delay the course of FI and improve the prognosis with timely intervention.
引用
收藏
页码:2314 / 2322
页数:9
相关论文
共 50 条
  • [21] Clinical Experience with Adalimumab in a Multicenter Swiss Cohort of Patients with Crohn's Disease
    Nichita, Cristina
    Stelle, Marc
    Vavricka, Stephan
    Ali, Abdou El-Wafa
    Ballabeni, Pierluigi
    de Saussure, Philippe
    Straumann, Alex
    Rogler, Gerhard
    Michetti, Pierre
    DIGESTION, 2010, 81 (02) : 78 - 85
  • [22] Nomogram to predict primary non-response to infliximab in patients with Crohn's disease: a multicenter study
    Ye, Xiao-Qi
    Cai, Jing
    Yu, Qiao
    Cao, Xiao-Cang
    Chen, Yan
    Rao, Mei-Xin
    Chen, Bai-Li
    He, Yao
    Zeng, Zhi-Rong
    Chen, Hao
    Lin, Yi-Mou
    Cao, Qian
    Chen, Min-Hu
    Zhang, Sheng-Hong
    GASTROENTEROLOGY REPORT, 2021, 9 (04): : 329 - 338
  • [23] Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort study
    Podmore, Belene
    Beier, Dominik
    Burisch, Johan
    Genestin, Elisabeth
    Haeckl, Dennis
    Nagel, Oliver
    Qizilbash, Nawab
    Schwartz, David A.
    Vavricka, Stephan R.
    Bennett, Dimitri
    Dignass, Axel
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2023, 11 (06) : 520 - 530
  • [24] Development of a prognostic model for one-year surgery risk in Crohn's disease patients: A retrospective study
    Yao, Jia-Yin
    Jiang, Yi
    Ke, Jia
    Lu, Yi
    Hu, Jun
    Zhi, Min
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (05) : 524 - 534
  • [25] Effectiveness and tolerability of methotrexate monotherapy in Crohn's disease patients: a multicenter observational study
    Park, Jihye
    Chun, Jaeyoung
    Park, Soo Jung
    Park, Jae Jun
    Kim, Tae Il
    Yoon, Hyuk
    Cheon, Jae Hee
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [26] Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study
    Choi, Chang Hwan
    Do Song, In
    Kim, Young-Ho
    Koo, Ja Seol
    Kim, You Sun
    Kim, Joo Sung
    Kim, Nayoung
    Kim, Eun Soo
    Kim, Jae Hak
    Kim, Ji Won
    Kim, Tae Oh
    Kim, Hyun Soo
    Kim, Hyo Jong
    Park, Young Sook
    Park, Dong Il
    Park, Soo Jung
    Song, Hyun Joo
    Shin, Sung Jae
    Yang, Suk-Kyun
    Ye, Byong Duk
    Lee, Kang-Moon
    Lee, Bo In
    Lee, Sun-Young
    Lee, Chang Kyun
    Im, Jong Pil
    Jang, Byung Ik
    Jeon, Tae Joo
    Cho, Yu Kyung
    Chang, Sae Kyung
    Jeon, Seong Ran
    Jung, Sung-Ae
    Jeen, Yoon Tae
    Cha, Jae Myung
    Han, Dong Soo
    Kim, Won Ho
    YONSEI MEDICAL JOURNAL, 2016, 57 (06) : 1376 - 1385
  • [27] 5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort study
    Atia, Ohad
    Goren, Idan
    Fischler, Tali Sharar
    Weisband, Yisca Loewenberg
    Greenfeld, Shira
    Kariv, Revital
    Ledderman, Natan
    Matz, Eran
    Rimon, Ramit Magen
    Dotan, Iris
    Turner, Dan
    Yanai, Henit
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (09) : 1004 - 1013
  • [28] Ferric carboxymaltose for anemia in Crohn's disease patients at a tertiary center: A retrospective observational cohort study
    Nunes Siqueira, Natalia Souza
    Pascoal, Livia Bitencourt
    Rodrigues, Bruno Lima
    de Castro, Marina Moreira
    Correa Martins, Alan Sidnei
    Silva Araujo, Dante Orsetti
    Miani Gomes, Luis Eduardo
    Camargo, Michel Gardere
    Setsuko Ayrizono, Maria de Lourdes
    Leal, Raquel Franco
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (12)
  • [29] Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort
    Isene, Rune
    Bernklev, Tomm
    Hoie, Ole
    Munkholm, Pia
    Tsianos, Epameonondas
    Stockbruegger, Reinhold
    Odes, Selwyn
    Palm, Oyvind
    Smastuen, Milada
    Moum, Bjorn
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (03) : 300 - 305
  • [30] Low Surgery Rates in Early Crohn's Disease: Results from a Prospective Population-Based Inception Cohort-The Inflammatory Bowel Disease in South-Eastern Norway III Study
    Lund, Charlotte
    Strande, Vibeke
    Hagen, Milada
    Bengtson, May-Bente
    Boyar, Raziye
    Detlie, Trond Espen
    Frigstad, Svein Oskar
    Medhus, Asle W.
    Henriksen, Magne
    Holten, Kristina I. Aass
    Hovde, Oistein
    Huppertz-Hauss, Gert
    Johansen, Ingunn
    Olsen, Bjorn Christian
    Opheim, Randi
    Pallenschat, Jens
    Perminow, Gori
    Ricanek, Petr
    Torp, Roald
    Ystrom, Carl Magnus
    Hoie, Ole
    Asak, Oivind
    Vatn, Simen
    Aabrekk, Tone Bergene
    Kristensen, Vendel A.
    Hoivik, Marte Lie
    INFLAMMATORY BOWEL DISEASES, 2024,